State Labs on Cutting Edge

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Contact
Floyd Wood
IBB
Contact Floyd Wood
Sidebar Content
No sidebar content submitted.
Summaries

Summary Sentence:

State Labs on Cutting Edge

Full Summary:

Georgia's small community of cutting-edge stem cell researchers got a boost this month when the first-ever trial testing a human embryonic stem cell therapy began at Atlanta's Shepherd Center. When it comes to stem cell research, California and Massachusetts lead the nation with hot-shot scientists and well-funded laboratories. But Georgia has its own stable of scientists working on the stem cell frontier, and the groundbreaking experiment launched on Peachtree Street could help raise the profile of Georgia's stem cell efforts.

Georgia's small community of cutting-edge stem cell researchers got a boost this month when the first-ever trial testing a human embryonic stem cell therapy began at Atlanta's Shepherd Center.

When it comes to stem cell research, California and Massachusetts lead the nation with hot-shot scientists and well-funded laboratories. But Georgia has its own stable of scientists working on the stem cell frontier, and the groundbreaking experiment launched on Peachtree Street could help raise the profile of Georgia's stem cell efforts.

Emory University, Georgia Tech and the University of Georgia all have scientists conducting advanced stem cell research. And the Shepherd Center can now boast that it is the first site in the world to test the safety of a treatment that scientists hope will someday help paralyzed patients walk again.

"Shepherd has now established their own precedent for running a stem cell-based clinical trial and that level of experience and expertise will be coveted," said Hans Keirstead, a neuroscientist at the University of California Irvine who pioneered the therapy being tested in the trial. "Absolutely, they will have a real leg up on the rest of the world."

Read Full Article

Additional Information

Groups

Parker H. Petit Institute for Bioengineering and Bioscience (IBB)

Categories
Institute and Campus, Cancer Research, Chemistry and Chemical Engineering, Student and Faculty, Engineering, Life Sciences and Biology, Nanotechnology and Nanoscience, Research, Physics and Physical Sciences
Related Core Research Areas
No core research areas were selected.
Newsroom Topics
No newsroom topics were selected.
Keywords
Georgia Tech, GTEC, IBB, Stem Cells
Status
  • Created By: Floyd Wood
  • Workflow Status: Published
  • Created On: Oct 17, 2010 - 8:00pm
  • Last Updated: Oct 7, 2016 - 11:07pm